RecruitingPhase 4NCT06723145

Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation

Sponsor

Kyoto University

Enrollment

1,200 participants

Start Date

Jan 20, 2025

Study Type

INTERVENTIONAL

Conditions

Perioperative Care Antiplatelet Agents

Summary

The purpose of this study is to evaluate the impact of perioperative aspirin continuation on clinical outcomes in patients with a history of coronary stent implantation who are scheduled for abdominal surgery.

Eligibility

Min Age: 20 Years

Inclusion Criteria2

Patients with a history of coronary stenting and scheduled for abdominal surgery
Patients on a single antiplatelet agent

Exclusion Criteria7

Patients on dual antiplatelet therapy (DAPT)
Patients on anticoagulation therapy
Patients with a history of stent thrombosis
Patients with CHADS2 score >= 5
Patients at extremely high risk of bleeding and unable to continue preoperative aspirin
Patients incapable of consent, including those under 20 years of age
Other patients for whom either discontinuation or continuation of antiplatelet agents is deemed inappropriate by the attending physician